Potencial antifúngico de Mitracarpus frigidus frente a isolados clínicos de Candida albicans: investigação do mecanismo de ação e desenvolvimento de sistemas poliméricos para o tratamento da candidíase mucosal
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Candidiasis represents a significant public health concern due to its high prevalence,
clinical recurrence, and increasing tolerance to conventional antifungal agents. In this
context, the prospecting of bioactive natural products and the development of
technological formulations constitute promising therapeutic strategies. Therefore, this
thesis aimed to investigate the antifungal potential of the methanolic extract of
Mitracarpus frigidus (MFM) against clinical isolates and reference strains of Candida
albicans, elucidate its possible antifungal mechanisms of action, and develop chitosanbased mucoadhesive polymeric systems for the treatment of vulvovaginal and oral
candidiasis. Initially, the antifungal activity of MFM was evaluated against 52 C.
albicans strains, including isolates obtained from vulvovaginal candidiasis, oral
candidiasis, COVID-19-associated coinfections, and ATCC strains. The extract
exhibited antifungal activity against all clinical profiles evaluated, demonstrating broadspectrum antifungal applicability (MIC = 62.5–100 µg/mL). Subsequently, studies were
conducted to investigate its mechanism of action. The results indicated that MFM acts
through a multifactorial mechanism, promoting cellular disorganization and impairing
important virulence factors of C. albicans. Ultrastructural analyses by electron
microscopy revealed alterations consistent with cell wall and membrane damage,
cytoplasmic disorganization, vacuolization, and mitochondrial impairment.
Phytochemical characterization by LC–MS/MS revealed a profile predominantly
composed of glycosylated flavonoids and phenolic acid derivatives, with quercetin-3-
O-galactoside, peltatoside, rutin, kaempferol, kaempferol-3-O-glycoside, quercetin,
and chlorogenic acid identified as major compounds. Based on the observed biological
potential, chitosan-based mucoadhesive films containing MFM were developed for
vaginal and oral applications. The systems were characterized regarding their
physicochemical, morphological, thermal, and mechanical properties using FTIR, TGA,
DSC, SEM, thickness, mechanical strength, swelling degree, mucoadhesion, surface
pH, and in vitro release profile analyses, demonstrating adequate uniformity,
physicochemical stability, swelling capacity, and sustained extract release.
Additionally, the systems showed in vitro biocompatibility, maintaining cell viability
above 70%. Finally, the therapeutic efficacy of the vaginal films was evaluated in an in
vivo experimental model of vulvovaginal candidiasis, in which MFM-loaded systems
reduced the vaginal fungal burden by 70.1% (QMFM 1%) and 100% (QMFM 2.5%), in
addition to improving inflammatory parameters. Collectively, the results demonstrate
that the methanolic extract of Mitracarpus frigidus exhibits significant antifungal and
antibiofilm activity against C. albicans, while the developed polymeric systems
represent promising platforms for the treatment of mucosal candidiasis. This research
is aligned with Sustainable Development Goal 3 (Good Health and Well-Being) of the
United Nations 2030 Agenda.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

